1. Copyright © 2012 American Medical Association. All rights reserved.
From: Tests and Expenditures in the Initial Evaluation of Peripheral Neuropathy
Arch Intern Med. 2012;172(2): doi: /archinternmed
Figure Legend:
Figure 1. Utilization of diabetic and American Academy of Neurology–recommended tests in 1031 patients with peripheral neuropathy. GTT indicates glucose tolerance test; HbA1c, hemoglobin A1c; and SPEP, serum protein electrophoresis.
Date of download: 10/24/2017
Copyright © 2012 American Medical Association. All rights reserved.

2. Copyright © 2012 American Medical Association. All rights reserved.
From: Tests and Expenditures in the Initial Evaluation of Peripheral Neuropathy
Arch Intern Med. 2012;172(2): doi: /archinternmed
Figure Legend:
Figure 2. Utilization of electromyography (EMG) and magnetic resonance imaging (MRI) in 1031 patients with peripheral neuropathy.
Date of download: 10/24/2017
Copyright © 2012 American Medical Association. All rights reserved.

3. Copyright © 2012 American Medical Association. All rights reserved.
From: Tests and Expenditures in the Initial Evaluation of Peripheral Neuropathy
Arch Intern Med. 2012;172(2): doi: /archinternmed
Figure Legend:
Figure 3. Utilization of common diagnostic tests in 1031 patients with peripheral neuropathy. ANA indicates antinuclear antibody; CBC, complete blood cell count; CMP, comprehensive metabolic panel; ESR, erythrocyte sedimentation rate; PT, prothrombin time; and PTT, partial thromboplastin time.
Date of download: 10/24/2017
Copyright © 2012 American Medical Association. All rights reserved.